Job Board > Post-Doctoral Fellow - Viral Immunology / SARS-CoV-2 - University Health Network / University of Toronto
This grant-funded post-doctoral fellowship position focuses on the intersection of SARS-Co-V2 pathogenesis and cardiovascular biology. The work will focus on genetically engineered mice and hamster models in order to develop strategies to prevent tissue injury and improve tissue healing.
The Epelman lab is seeking an enthusiastic, highly motivated, organized individual with exceptional interpersonal skills who will enjoy collaborating and conducting research in a stimulating environment. As a key member of the Epelman lab, the successful candidate will investigate the pathologic effects of SARS-CoV2 on the cardiovascular system using a variety of immunological and genetic techniques. The work will be done in a containment level 3 facility equipped with the latest immunological, genomics research tools and animal imaging tools. The successful candidate will also receive training and mentorship in key developmental areas. These areas include grant writing, manuscript review, supervision of trainees, and conference travel and networking opportunities.
• Use immunological and genetic techniques to investigate the pathologic effects of SARS-CoV2 on the cardiovascular system
• Perform work in a containment level 3 facility
• Assist in grant writing and progress reports
• Review manuscripts
• Supervise trainees
• PhD received within 5 years in Biological Sciences, Virology, or Immunology (or MD received within 10 years)
• Expertise in Virology
• Expertise with animal models and genetically modified mice
• Expertise in flow cytometry, cell sorting and immunological assays
• Experience in some or all of the following techniques: tissue processing, imaging (e.g. confocal microscopy), molecular biology techniques (real-time gene expression, gene expression arrays, RNA sequencing)
• Demonstrated ability to work independently and as part of a team
• Self-motivated, detail-oriented, and results-oriented
• Excellent verbal and written communication skills
• Publications in high quality journals required (minimum of 3 publications, at least 1 first author)
- Learn to write successful grants
- Direct mentorship to achieve your career goals
- Opportunities for networking in cardio-immunology, virology, bioengineering communities
- Opportunities in entrepreneurship (https://tedrogersresearch.ca/echo-discovery/)
- Participate in the Emerging & Pandemic Infections Consortium (EPIC) (https://epic.utoronto.ca/)
- Be a part of the Ted Rogers Centre for Heart Failure (https://tedrogersresearch.ca/)
Salary: Based on background
The University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.
The Epelman lab is located at the MaRS Discovery District in the heart of downtown Toronto, a hub for medical research, technology, and business. MaRS is situated between the world-renowned University Health Network (UHN) and the University of Toronto, making it an ideal location for multidisciplinary collaboration with clinicians and investigators across various hospitals and research institutes.
Dr. Slava Epelman is a Clinician-Scientist in the Department of Medicine, Division of Cardiology at the University Toronto, Peter Munk Cardiac Centre, a Senior Scientist and Cardiovascular Research Group lead at the Toronto General Research Institute, University Health Network, and the Loretta Rogers Chair in Immunobioengineering for the Ted Rogers Centre for Heart Research, University of Toronto. Dr. Epelman obtained his MD / PhD (in Immunology) from the University of Calgary and then did his medical residency and clinical fellowships at the Cleveland Clinic, Baylor College of Medicine and Washington University. He is a staff cardiologist in the Peter Munk Cardiac Centre at the Toronto General Hospital. His scientific interests are focused on the role of macrophages in cardiac tissue injury and regeneration.